"use strict";(self.webpackChunkgenomics_docusaurus_new=self.webpackChunkgenomics_docusaurus_new||[]).push([[602],{695:(e,n,i)=>{i.r(n),i.d(n,{assets:()=>d,contentTitle:()=>s,default:()=>p,frontMatter:()=>a,metadata:()=>o,toc:()=>l});const o=JSON.parse('{"id":"oncology-europe/index","title":"Cancer Incidence & Projection","description":"Cancer Incidence & Projection","source":"@site/docs/oncology-europe/index.md","sourceDirName":"oncology-europe","slug":"/oncology-europe/","permalink":"/datasolutions/oncology-europe/","draft":false,"unlisted":false,"tags":[],"version":"current","sidebarPosition":1,"frontMatter":{"id":"index","title":"Cancer Incidence & Projection","sidebar_position":1,"hide_title":true},"sidebar":"docsSidebar","previous":{"title":"Roche Sequencing by Extension (SBX)","permalink":"/datasolutions/academic-research/platform-costs"},"next":{"title":"Incidence & Cost Scenarios","permalink":"/datasolutions/oncology-europe/incidence-cost-scenarios"}}');var t=i(4848),c=i(8453),r=i(6025);const a={id:"index",title:"Cancer Incidence & Projection",sidebar_position:1,hide_title:!0},s=void 0,d={},l=[{value:"Cancer Incidence &amp; Projection",id:"cancer-incidence--projection",level:2}];function u(e){const n={a:"a",h2:"h2",hr:"hr",p:"p",...(0,c.R)(),...e.components};return(0,t.jsxs)(t.Fragment,{children:[(0,t.jsx)(n.h2,{id:"cancer-incidence--projection",children:"Cancer Incidence & Projection"}),"\n",(0,t.jsx)(n.hr,{}),"\n",(0,t.jsxs)(n.p,{children:["Cancer incidence is rising globally, with the number of new cases projected to nearly double by 2050 compared to 2025 (",(0,t.jsx)(n.a,{href:"https://www.iarc.who.int/",children:"WHO International Agency for Research on Cancer"}),"). In this context, I have explored the financial landscape of genomic sequencing in oncology, with a particular emphasis on Europe."]}),"\n",(0,t.jsxs)(n.p,{children:["While sequencing may not always be pivotal for initial diagnosis, it plays a critical role in guiding therapeutic decision-making and treatment stratification. I have a strong personal interest in colorectal and lung cancer subtypes, due to their incidence on the maternal side of my family ",(0,t.jsx)(n.a,{href:"https://en.wikipedia.org/wiki/Portuguese_India",children:"originating from Goa"}),", which forced me to a prolonged career break. Such experience, however, has given me a detailed understanding of the key biomarkers and current therapeutic lines for these cancers."]}),"\n",(0,t.jsx)("br",{}),"\n",(0,t.jsx)("br",{}),"\n",(0,t.jsxs)("p",{align:"center",children:[(0,t.jsx)("img",{src:(0,r.Ay)("/files/cancer_new_cases.png"),alt:"Projected Global Cancer Cases",width:"100%"}),(0,t.jsx)("img",{src:(0,r.Ay)("/files/heatmap_common_world.png"),alt:"Cancer Subtype Distribution",width:"100%"})]})]})}function p(e={}){const{wrapper:n}={...(0,c.R)(),...e.components};return n?(0,t.jsx)(n,{...e,children:(0,t.jsx)(u,{...e})}):u(e)}},8453:(e,n,i)=>{i.d(n,{R:()=>r,x:()=>a});var o=i(6540);const t={},c=o.createContext(t);function r(e){const n=o.useContext(c);return o.useMemo((function(){return"function"==typeof e?e(n):{...n,...e}}),[n,e])}function a(e){let n;return n=e.disableParentContext?"function"==typeof e.components?e.components(t):e.components||t:r(e.components),o.createElement(c.Provider,{value:n},e.children)}}}]);